← Back to Clinical Trials
Recruiting NCT05391672

NCT05391672 Augmentation of Partial Anterior Cruciate Ligament Tear: Early Results

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05391672
Status Recruiting
Phase
Sponsor Assiut University
Condition ACL Injury
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2022-06-09
Primary Completion 2026-03-19

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
we will do ACL augmentation surgery to the patients who have partial ACL tear

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2022-06-09 with a primary completion date of 2026-03-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Clinical evaluation for the patients with partial ACL tear who had ACL augmentation

Eligibility Criteria

Inclusion Criteria: * age from 15 to 50 years old * Partial ACL tear without any other ligament injury * with and without meniscal tear * with and without knee deformity * recent and chronic injury Exclusion Criteria: * younger than 15 and older than 50 y * multiligament injury * complete ACL tear * failed ACL reconstruction or repair

Contact & Investigator

Central Contact

Michael Mikhaeil, Resident

✉ mickelmikhaa5@gmail.com

📞 01289375910

Principal Investigator

Mohamed Abd-El Radi, Lecturer

STUDY DIRECTOR

Orthopaedic Department , Faculty of medicine, Assiut University

Frequently Asked Questions

Who can join the NCT05391672 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 50 Years, studying ACL Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05391672 currently recruiting?

Yes, NCT05391672 is actively recruiting participants. Contact the research team at mickelmikhaa5@gmail.com for enrollment information.

Where is the NCT05391672 trial being conducted?

This trial is being conducted at Asyut, Egypt.

Who is sponsoring the NCT05391672 clinical trial?

NCT05391672 is sponsored by Assiut University. The principal investigator is Mohamed Abd-El Radi, Lecturer at Orthopaedic Department , Faculty of medicine, Assiut University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology